Critical find in understanding sex disorder development

Proudly supported by

  Last updated December 18, 2018 at 3:03 pm

Topics:  

Unusual ovary and testes formation may be triggered by ‘genetic regulator’.


One in 4500 people is born with a sex organ development disorder. Credit: Shaun Taylor/Getty Images




Australian researchers have discovered a genetic regulator that plays a key role in determining a baby’s sex and, crucially, whether it will become one of the one in every 4500 people with a disorder of sex development.


Led by Andrew Sinclair at the Murdoch Children’s Research Institute (MCRI) in Melbourne, the team isolated a group of so-called “enhancers” that act on a gene that controls the growth of testes in the foetus.


At a basic level, if you’re born with two X chromosomes you become a girl, and if you have an X and a Y chromosome you’re a boy. But whether that genetic blueprint leads to typically male or female gonads, the testes and ovaries, and genitalia, the penis and scrotum, or vulva, vagina and clitoris, depends on a host of other factors.


One of those is the SRY gene, which sits on the Y chromosome and activates another gene called SOX9. It is SOX9 that tells the embryonic gonads, which can go either way, to head down the testes path.


How SRY influences SOX9 has been an enduring mystery, but at least part of the enigma is now in daylight.


The researchers found that three enhancers – sections of DNA that regulate gene expression – are drivers of SOX9, with profound implications when it all goes wrong.


In an analysis of 44 patients with disorders of sex development, the team found four people with mutations causing either duplications or deletions of the enhancers. Those changes resulted in something called complete sex reversal.


Duplications caused XX patients to develop testes, while deletions in XY patients caused a failure of testicular development and, instead, the growth of ovaries.


It is a finding that could, Sinclair explains, open up new lines of diagnosis for a group of disorders in which a genetic cause is found in only two out of five people.


“These enhancers lie on the DNA but outside genes, in regions previously referred to as junk DNA or dark matter,” says Sinclair.


“The key to diagnosing many disorders may be found in these enhancers which hide in the poorly understood dark matter of our DNA.”


The researchers write that this “gene desert” is often excluded in genetic screens for disorders of sex development and should now be considered in unexplained cases.


It is a point reinforced by first author and MCRI PhD student, Brittany Croft: “This study is significant because in the past researchers have only looked at genes to diagnose these patients, but we have shown you need to look outside the genes to the enhancers.”


The research is published in the journal Nature Communications.






About the Author

Paul Biegler
Paul Biegler is a philosopher, physician and Adjunct Research Fellow in Bioethics at Monash University. He received the 2012 Australasian Association of Philosophy Media Prize and his book The Ethical Treatment of Depression (MIT Press 2011) won the Australian Museum Eureka Prize for Research in Ethics.

Published By

Cosmos is a quarterly science magazine. We aim to inspire curiosity in ‘The Science of Everything’ and make the world of science accessible to everyone.


At Cosmos, we deliver the latest in science with beautiful pictures, clear explanations of the latest discoveries and breakthroughs and great writing.


Winner of 47 awards for high-quality journalism and design, Cosmos is a print magazine, online digital edition updated daily, a daily and weekly e-Newsletter and educational resource with custom, curriculum-mapped lessons for years 7 to 10.


Featured Videos

Placeholder
Fitting natural water treatment processes back into the landscape
Placeholder
Protecting the Great Barrier Reef at the National Sea Simulator